Psoriatic skin molecular and histopathological profiles following treatment with risankizumab versus ustekinumab

This study reports insights into early changes in the histopathology and transcriptomic profiles of skin and blood in patients with psoriasis treated with risankizumab compared with ustekinumab. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2BxZlyJ